Joint Base San Antonio > News

JBSA News

Tag: Pfizer BioNTech COVID-19 vaccine

TRICARE beneficiaries ages 5-11 now eligible for COVID-19 vaccine
November 18, 2021 — On Nov. 2, the Centers for Disease Control and Prevention endorsed the use of the Pfizer-BioNTech COVID-19 vaccine for children ages 5 to 11. It’s the latest of several important steps taken by the federal government to end the pandemic... MORE

MEDCoE trainees receive COVID-19 vaccine
April 22, 2021 — Trainees assigned to the U.S. Army Medical Center of Excellence, or MEDCoE, began receiving the COVID-19 vaccine at the Joint Base San Antonio-Fort Sam Houston vaccine site April 15. As Brooke Army Medical Center, or BAMC, announced that vaccines are now available to all beneficiaries 16 and older, MEDCoE trainees were offered the vaccine as a Tier II priority. ... MORE

Pvt. Michael Giuffrida, a 68K medical laboratory specialist in training at the U.S. Army Medical Center of Excellence, or MEDCoE, is administered the first dose of the Pfizer BioNTech COVID-19 vaccine by Sgt. 1st Class Victoria Romero, MEDCoE 68W Combat Medic cadre augmenting staff, at the Brooke Army Medical Center’s Joint Base San Antonio-Fort Sam Houston Vaccine site April 15.